The COVID-19 pandemic created ripple effects across all of health care, especially for at-risk populations like cancer patients. Early in the pandemic, the National Cancer Institute initiated a study to examine the intersection of cancer and COVID-19 diagnoses. More than two years later, we discuss with NCI Head of Breast Cancer and Melanoma Therapeutics Dr. Larissa Korde from the Clinical Investigations Branch on the status of the study, some of the preliminary findings and how it’s evolved.
Cancer HealthCast
26m listen
A Look Into COVID-19’s Impact on Cancer Patients

An NCI study examines the crossroads between cancer and COVID-19 diagnoses.

-
Dr. Larissa Korde Head, Breast Cancer and Melanoma Therapeutics NCI
Related Content
-
AFCEA West: AI is America’s ‘Sputnik Moment,’ Defense Academic Says
NPS president says that ‘warrior scholars’ bridge research and implementable capabilities for national security.
12m listen -
Defending the Cyber Domain in a Time of 'Non-Kinetic' Threats
Northcom's intelligence leader Brig. Gen. Maurizio Calabrese discussed the evolving role of defense intelligence technology.
20m watch -
The Year Ahead: FBI’s 2025 Cybersecurity Priorities
The FBI is increasing awareness of vulnerabilities and employing AI-enabled tools to secure networks from sophisticated cyber threats.
25m listen -
OPM Navigates AI Governance Through People
OPM's Taka Ariga explores AI's role in an efficient federal workforce and operations, focusing on trust, data integrity and storytelling.
19m listen